These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19056339)

  • 1. Distinct properties of cyclin-dependent kinase complexes containing cyclin A1 and cyclin A2.
    Joshi AR; Jobanputra V; Lele KM; Wolgemuth DJ
    Biochem Biophys Res Commun; 2009 Jan; 378(3):595-9. PubMed ID: 19056339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks.
    Upton JW; van Dyk LF; Speck SH
    Virology; 2005 Oct; 341(2):271-83. PubMed ID: 16102793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and evaluation of dual CDK1 and CDK2 inhibitors.
    Payton M; Chung G; Yakowec P; Wong A; Powers D; Xiong L; Zhang N; Leal J; Bush TL; Santora V; Askew B; Tasker A; Radinsky R; Kendall R; Coats S
    Cancer Res; 2006 Apr; 66(8):4299-308. PubMed ID: 16618755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of a CDK2-docking site peptide that inhibits p53 and sensitizes cells to death.
    Ferguson M; Luciani MG; Finlan L; Rankin EM; Ibbotson S; Fersht A; Hupp TR
    Cell Cycle; 2004 Jan; 3(1):80-9. PubMed ID: 14657672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
    Meijer L; Borgne A; Mulner O; Chong JP; Blow JJ; Inagaki N; Inagaki M; Delcros JG; Moulinoux JP
    Eur J Biochem; 1997 Jan; 243(1-2):527-36. PubMed ID: 9030781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular models of cyclin-dependent kinase 1 complexed with inhibitors.
    Canduri F; Uchoa HB; de Azevedo WF
    Biochem Biophys Res Commun; 2004 Nov; 324(2):661-6. PubMed ID: 15474478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical characterization of Cdk2-Speedy/Ringo A2.
    Cheng A; Gerry S; Kaldis P; Solomon MJ
    BMC Biochem; 2005 Sep; 6():19. PubMed ID: 16191191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the Conformational Energy Landscape of CDK1 and CDK2 Suggest a Mechanism for Achieving Selective CDK Inhibition.
    Wood DJ; Korolchuk S; Tatum NJ; Wang LZ; Endicott JA; Noble MEM; Martin MP
    Cell Chem Biol; 2019 Jan; 26(1):121-130.e5. PubMed ID: 30472117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct activation pathways confer cyclin-binding specificity on Cdk1 and Cdk2 in human cells.
    Merrick KA; Larochelle S; Zhang C; Allen JJ; Shokat KM; Fisher RP
    Mol Cell; 2008 Dec; 32(5):662-72. PubMed ID: 19061641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1).
    Göke R; Barth P; Schmidt A; Samans B; Lankat-Buttgereit B
    Am J Physiol Cell Physiol; 2004 Dec; 287(6):C1541-6. PubMed ID: 15317660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Putting one step before the other: distinct activation pathways for Cdk1 and Cdk2 bring order to the mammalian cell cycle.
    Merrick KA; Fisher RP
    Cell Cycle; 2010 Feb; 9(4):706-14. PubMed ID: 20139727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functions of cyclin A1 in the cell cycle and its interactions with transcription factor E2F-1 and the Rb family of proteins.
    Yang R; Müller C; Huynh V; Fung YK; Yee AS; Koeffler HP
    Mol Cell Biol; 1999 Mar; 19(3):2400-7. PubMed ID: 10022926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin A1 is a p53-induced gene that mediates apoptosis, G2/M arrest, and mitotic catastrophe in renal, ovarian, and lung carcinoma cells.
    Rivera A; Mavila A; Bayless KJ; Davis GE; Maxwell SA
    Cell Mol Life Sci; 2006 Jun; 63(12):1425-39. PubMed ID: 16799873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of interaction partners and substrates of the cyclin A1-CDK2 complex.
    Diederichs S; Bäumer N; Ji P; Metzelder SK; Idos GE; Cauvet T; Wang W; Möller M; Pierschalski S; Gromoll J; Schrader MG; Koeffler HP; Berdel WE; Serve H; Müller-Tidow C
    J Biol Chem; 2004 Aug; 279(32):33727-41. PubMed ID: 15159402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin A2-CDK2 regulates embryonic gene activation in 1-cell mouse embryos.
    Hara KT; Oda S; Naito K; Nagata M; Schultz RM; Aoki F
    Dev Biol; 2005 Oct; 286(1):102-13. PubMed ID: 16137671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different mechanisms of CDK5 and CDK2 activation as revealed by CDK5/p25 and CDK2/cyclin A dynamics.
    Otyepka M; Bártová I; Kríz Z; Koca J
    J Biol Chem; 2006 Mar; 281(11):7271-81. PubMed ID: 16407256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual blockade of lipid and cyclin-dependent kinases induces synthetic lethality in malignant glioma.
    Cheng CK; Gustafson WC; Charron E; Houseman BT; Zunder E; Goga A; Gray NS; Pollok B; Oakes SA; James CD; Shokat KM; Weiss WA; Fan QW
    Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12722-7. PubMed ID: 22802621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes.
    Sarcevic B; Lilischkis R; Sutherland RL
    J Biol Chem; 1997 Dec; 272(52):33327-37. PubMed ID: 9407125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual regulation of the anaphase promoting complex in human cells by cyclin A-Cdk2 and cyclin A-Cdk1 complexes.
    Mitra J; Enders GH; Azizkhan-Clifford J; Lengel KL
    Cell Cycle; 2006 Mar; 5(6):661-6. PubMed ID: 16582612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of cyclin A does not require its phosphorylation by CDC2 and cyclin-dependent kinase 2.
    Yam CH; Siu WY; Lau A; Poon RY
    J Biol Chem; 2000 Feb; 275(5):3158-67. PubMed ID: 10652300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.